Ibacitabine

This classification denotes a pyrimidine antagonist and antiviral agent with the molecular formula C9H12IN3O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 3EK8532DZV, chemically known as cytidine, 2-deoxy-5-iodo- (8ci)(9ci) but generally known as ibacitabine, which bears US NIH Compound Identifier 65050. European Medicines Agency schedules Ibacitabine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08090MIG. The term IBACITABINE is an International Non-Proprietary Name. World Health Organization schedules ibacitabine in its Anatomical Therapeutic Chemical (ATC) Classification. IBACITABINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule ibacitabine under HS 29349990 and SITC 51579. As of Q4 2014, IBACITABINE remains the US FDA Preferred Term for this commodity. Ibacitabine bears US NLM identifiers UMLS ID C0049263 and NCI Concept Code C83771. SMILES: IC1CN(C2OC(C(O)C2)CO)C(=O)NC1N.